CHICAGO: Study provides preliminary evidence in favor of a new type 1 diabetes treatment
|
CHICAGO: Pursuing equity in diagnosis of MODY and other atypical forms of diabetes
|
MICHIGAN: Research finds potential target for cardiovascular disease in diabetes
|
YALE: Prediabetes Is on the Rise—But It Can Be Reversed
|
YALE: Prediabetes Is on the Rise—But It Can Be Reversed
|
YALE: Type 1 Diabetes Drug, Teplizumab, Has Additional Benefits, New Study Shows
|
STANFORD: Why precision medicine leads to better diabetes care
|
VANDERBILT: Powers announces plan to step down from key diabetes leadership roles
|
UAB: In Type 1 diabetes, verapamil prevents decline of IGF-1 and promotes beta-cell IGF-1 signaling
|
UAB: Diabetes diagnoses might get much more specific in the future, UAB expert says
|